Volume 10, Number 12—December 2004
Cryptosporidium felis and C. meleagridis in Persons with HIV, Portugal
Highlight and copy the desired format.
|EID||Matos O, Alves M, Xiao L, Cama V, Antunes F. Cryptosporidium felis and C. meleagridis in Persons with HIV, Portugal. Emerg Infect Dis. 2004;10(12):2256-2257. https://dx.doi.org/10.3201/eid1012.031068|
|AMA||Matos O, Alves M, Xiao L, et al. Cryptosporidium felis and C. meleagridis in Persons with HIV, Portugal. Emerging Infectious Diseases. 2004;10(12):2256-2257. doi:10.3201/eid1012.031068.|
|APA||Matos, O., Alves, M., Xiao, L., Cama, V., & Antunes, F. (2004). Cryptosporidium felis and C. meleagridis in Persons with HIV, Portugal. Emerging Infectious Diseases, 10(12), 2256-2257. https://dx.doi.org/10.3201/eid1012.031068.|
To the Editor: Cryptosporidium, a pathogenic protozoan parasite with a worldwide distribution, causes diarrheal illness in humans and animals. The parasite can be transmitted from human to human through fecal-oral contact (household contact and nosocomial transmission), sexual contact, ingestion of contaminated food or water, and contact with infected animals. Molecular diagnostic methods indicate that Cryptosporidium parvum and C. hominis are the major causes of cryptosporidiosis in humans, and other Cryptosporidium species can be associated with human infection (1–5).
In Portugal, patients with AIDS have an 8% prevalence rate of cryptosporidiosis (6) with C. parvum and C. hominis as the etiologic agents, even though other Cryptosporidium species were found in these patients (3,7,8). This study characterizes clinical manifestations of infections with unusual two different Cryptosporidium species isolated from seven patients and demonstrates that these species can cause life-threatening disease.
Cryptosporidiosis was diagnosed in 40 patients from 1994 through 2002. All patients were serologically positive for HIV-1 and had diarrhea (at least two loose stools per day) when diagnosed with cryptosporidiosis. Demographic, clinical, and immunologic data were obtained from each patient’s records. Cryptosporidium oocysts were identified by light microscopy after concentration from fecal material by a modified water-ether sedimentation method followed by the modified Ziehl-Neelsen staining (7). The intensity of infection was quantified before molecular analysis by scoring the number of oocysts counted per microscopic field (under a 20x objective) of 50-µL volume of concentrated stool sample as + (1–5 oocysts), ++ (6–10 oocysts), +++ (11–15 oocysts), or ++++ (>15 oocysts). Genetic characterization of the isolates was based on polymerase chain reaction–restriction fragment length polymorphism analysis of the small subunit rRNA gene (2,3).
The molecular analysis showed that 22 patients (55%) were infected with C. parvum, 11 (27.5%) were infected with C. hominis, 4 (10%) were infected with C. felis, and 3 (7.5%) were infected with C. meleagridis. Of the four patients infected with C. felis, three (75%) showed low (+) and one (25%) showed moderate (++) oocyst loads. All three (100%) patients infected with C. meleagridis showed low oocyst loads (+). In contrast, of the 22 patients infected with C. parvum, 9 (41%) showed low oocyst loads (+), 3 (14%) showed moderate oocyst loads (++), 3 (14%) showed high oocyst loads (+++), and 7 (32%) showed very high (++++) oocyst loads. Similarly, of the 11 patients infected with C. hominis, 2 (18%) had low oocyst loads (+), and 3 (27%) each had moderate (++), high (+++), or very high (++++) oocyst loads.
Five of the seven patients infected with C. felis and C. meleagridis were men and two were women; the median age of patients was 31 years (7–44). In this group of HIV-positive patients, three were heterosexual persons, two were homosexual persons, one was an intravenous drug user, and one acquired HIV infection through vertical transmission. Of the seven patients, all showed a range of clinical manifestations of infection, including transient diarrhea, chronic diarrhea, dehydration, and cachexia. Five (71%) of the patients spontaneously recovered, and two (29%) of the patients died. The median CD4+ count/mm3 was 20 (18–213).
All of the seven patients were prescribed antiretroviral therapy, but one of the patients did not adhere to the treatment. Two of the three patients infected with C. meleagridis died of cryptosporidiosis. Information on the risk factors for acquiring Cryptosporidium infection was available for one patient, the child infected with C. felis, who had contact with cats at home. No other potential intestinal pathogens were detected in the feces of these patients at the time of the cryptosporidiosis diagnosis.
Twenty-two of the 33 patients infected with C. parvum and C. hominis were men and 11 were women; the median age of patients was 32 years (7–58). Sixteen patients were intravenous drug users, 5 patients were heterosexual persons, 1 patient was a homosexual person, and 2 patients acquired HIV infection through vertical transmission; the remaining 9 patients had no HIV-exposure history information. Eighteen of the 22 patients infected with C. parvum showed a range of clinical manifestations of illness with transient diarrhea, chronic diarrhea, dehydration, and cachexia. Twelve (67%) of the patients spontaneously recovered, and 6 (33%) of the patients died. Information on CD4+ count/mm3 was available for 13 of the 22 patients with a median count of 20 (3–250). Information on the outcome of the patients infected with C. hominis was available for 10 of the 11 patients. All of the 10 patients showed a range of clinical manifestations of infection, including transient diarrhea, chronic diarrhea, dehydration, and cachexia. Seven (70%) of the patients spontaneously recovered, and 3 (30%) of the patients died. The median CD4+ count/mm3 was 20 (6–40).
Most reports on infections with unusual Cryptosporidium species in humans give a brief description of the genotyping results, leaving the clinical importance of these species uncertain. Unusual Cryptosporidium species can cause disease (symptomatic infection) and death. C. felis and C. meleagridis infections showed low oocyst shedding (all seven patients had low to moderate oocyst loads in samples). On the contrary, C. parvum produced similar clinical manifestations but showed higher oocyst shedding; 46% had high to very high parasite loads. C. hominis infections had parasite loads even higher than C. parvum infections; 54% of patients had high to very high parasite loads. In immunocompetent persons, C. hominis infections produce higher oocyst loads in feces than infections caused by C. parvum or zoonotic species (2,9).
The transmission route for the unusual Cryptosporidium species is unclear. Because human infection by unusual Cryptosporidium species is less common, the principal transmission route for these parasites is likely through direct contact with infected animals. In our study, one of the four immunocompromised patients with C. felis was a child who had been in close contact with cats at home. No data on animal contact were available for other patients infected with unusual Cryptosporidium species. Cats are found in many homes with no evidence of cryptosporidiosis; therefore, it is difficult to attribute the occasional human C. felis infection to contamination by cats. Careful epidemiologic studies are needed to elucidate the transmission route of human infections with unusual Cryptosporidium species.
This work was supported by Fundação para a Ciência e Tecnologia / European Union / Fonds Social Européen / Fonds Européen de Développement Régional.
- McLauchlin J, Amar C, Pedraza-Díaz S, Nichols GL. Molecular epidemiological analysis of Cryptosporidium spp. in the United Kingdom: results of genotyping Cryptosporidium spp. in 1,705 fecal samples from humans and 105 fecal samples from livestock animals. J Clin Microbiol. 2000;38:3984–90.
- Xiao L, Bern C, Limor J, Sulaiman I, Roberts J, Checkley W, Identification of 5 types of Cryptosporidium parasites in children in Lima, Peru. J Infect Dis. 2001;183:492–7.
- Alves M, Matos O, Antunes F. Multilocus PCR-RFLP analysis of Cryptosporidium isolates from HIV-infected patients from Portugal. Ann Trop Med Parasitol. 2001;95:627–32.
- Guyot K, Follet-Dumoulin A, Lelièvre E, Sarfati C, Rabodonirina M, Nevez G, Molecular characterization of Cryptosporidium isolates obtained from humans in France. J Clin Microbiol. 2001;39:3472–80.
- Xiao L, Fayer R, Ryan U, Upton SJ. Cryptosporidium taxonomy: recent advances and implications for public health. Clin Microbiol Rev. 2004;17:72–97.
- Matos O, Tomás A, Aguiar P, Casemore D, Antunes F. Prevalence of cryptosporidiosis in AIDS patients with diarrhoea in Santa Maria Hospital, Lisbon. Folia Parasitol (Praha). 1998;45:163.
- Alves M, Matos O, Spano F, Antunes F. PCR-RFLP analysis of Cryptosporidium parvum isolates from HIV-infected patients in Lisbon, Portugal. Ann Trop Med Parasitol. 2000;94:291–7.
- Alves M, Matos O, Fonseca IP, Delgado E, Lourenço AM, Antunes F. Multilocus genotyping of Cryptosporidium isolates from human HIV-infected and animal hosts. J Eukaryot Microbiol. 2001;Suppl:17S–8S.
- McLauchlin J, Pedraza-Díaz S, Amar-Hoetzeneder C, Nichols GL. Genetic characterization of Cryptosporidium stains from 218 patients with diarrhea diagnosed as having sporadic cryptosporidiosis. J Clin Microbiol. 1999;37:3153–8.
Please use the form below to submit correspondence to the authors or contact them at the following address:
Olga M. Matos, Unidade de Protozoários Oportunistas/VIH e outras Protozooses, Instituto de Higiene e Medicina Tropical, Rua da Junqueira 96, 1349-008 Lisboa, Portugal; fax: 00-351-213632105
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: April 14, 2011
- Page last updated: April 14, 2011
- Page last reviewed: April 14, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)